Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.
Serova M, Tijeras-Raballand A, Dos Santos C, Martinet M, Neuzillet C, Lopez A, Mitchell DC, Bryan BA, Gapihan G, Janin A, Bousquet G, Riveiro ME, Bieche I, Faivre S, Raymond E, de Gramont A. Serova M, et al. Oncotarget. 2016 Jun 21;7(25):38467-86. doi: 10.18632/oncotarget.9542. Oncotarget. 2016. PMID: 27509260 Free PMC article.
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.
Neuzillet C, Hammel P, Tijeras-Raballand A, Couvelard A, Raymond E. Neuzillet C, et al. Cancer Metastasis Rev. 2013 Jun;32(1-2):147-62. doi: 10.1007/s10555-012-9396-2. Cancer Metastasis Rev. 2013. PMID: 23085856 Review.
Stromal expression of SPARC in pancreatic adenocarcinoma.
Neuzillet C, Tijeras-Raballand A, Cros J, Faivre S, Hammel P, Raymond E. Neuzillet C, et al. Cancer Metastasis Rev. 2013 Dec;32(3-4):585-602. doi: 10.1007/s10555-013-9439-3. Cancer Metastasis Rev. 2013. PMID: 23690170 Review.
Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Neuzillet C, Albert S, Raymond E, Faivre S. Astorgues-Xerri L, et al. Cancer Treat Rev. 2014 Mar;40(2):307-19. doi: 10.1016/j.ctrv.2013.07.007. Epub 2013 Aug 1. Cancer Treat Rev. 2014. PMID: 23953240 Review.
MEK in cancer and cancer therapy.
Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Neuzillet C, et al. Pharmacol Ther. 2014 Feb;141(2):160-71. doi: 10.1016/j.pharmthera.2013.10.001. Epub 2013 Oct 9. Pharmacol Ther. 2014. PMID: 24121058 Review.
30 results